Sorafenib enhances graft-versus-leukemia activity through IL-18-mediated macrophage and NK cell crosstalk in FLT3-ITD acute myeloid leukemia. (linkinghub.elsevier.com)

Authors: Shao R … Xuan L Journal: Cell Reports Published: 2026-09-22 DOI: https://doi.org/10.1016/j.celrep.2026.118083